Home » Clinilabs chosen for COPD trial
Clinilabs chosen for COPD trial
April 27, 2011
CRO Clinilabs, a company that provides early-stage and clinical drug development services, has been selected to conduct a phase I clinical research study of an investigational medication in patients with chronic obstructive pulmonary disease (COPD).
This is Clinilabs’ third clinical trial examining drug effects in patients with COPD. “As a specialty CRO, it is exciting to grow our franchise in respiratory disorders as we expand our expertise to an ever wider range of conditions” states Barbara Smallwood, vice president of business development at Clinilabs.
Upcoming Events
-
21Oct